Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone Pharmacokinetics in Healthy Volunteers
NCT02607657Phase 1Withdrawn
- Sponsor
- Biolab Farmacêutica
- Start
- May 2016
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised, open-label trial of eplerenone in hypertension (HTN) and heart failure (HF) (5 arms), sponsored by Biolab Farmacêutica. Primary endpoints: Area under the curve(0-last) at 24 hours, Area under the curve(0-all) at 24 hours and 7 more. Planned start May 2016; status: withdrawn.
02
Drugs
eplerenone
03
Conditions
hypertension (HTN)heart failure (HF)
Beyond the preview
Go deeper on NCT02607657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02607657.